Gerard Esteban

1.1k total citations
16 papers, 957 citations indexed

About

Gerard Esteban is a scholar working on Pharmacology, Computational Theory and Mathematics and Physiology. According to data from OpenAlex, Gerard Esteban has authored 16 papers receiving a total of 957 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 7 papers in Computational Theory and Mathematics and 7 papers in Physiology. Recurrent topics in Gerard Esteban's work include Cholinesterase and Neurodegenerative Diseases (11 papers), Computational Drug Discovery Methods (7 papers) and Alzheimer's disease research and treatments (6 papers). Gerard Esteban is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (11 papers), Computational Drug Discovery Methods (7 papers) and Alzheimer's disease research and treatments (6 papers). Gerard Esteban collaborates with scholars based in Spain, United Kingdom and United States. Gerard Esteban's co-authors include Mercedes Unzeta, José Marco‐Contelles, Irene Bolea, Abdelouahid Samadi, Ignacio Moraleda, Isabel Iriepa, Rona R. Ramsay, Katarina Nikolić, Danica Agbaba and Moussa B. H. Youdim and has published in prestigious journals such as Progress in Neurobiology, British Journal of Pharmacology and European Journal of Medicinal Chemistry.

In The Last Decade

Gerard Esteban

16 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerard Esteban Spain 13 671 434 350 265 241 16 957
Zonghua Luo United States 18 632 0.9× 366 0.8× 402 1.1× 345 1.3× 282 1.2× 38 1.2k
Tarek Mohamed Canada 20 488 0.7× 335 0.8× 314 0.9× 266 1.0× 377 1.6× 25 995
Neng Jiang China 16 697 1.0× 397 0.9× 419 1.2× 257 1.0× 250 1.0× 33 1.0k
Nasimul Hoda India 21 498 0.7× 375 0.9× 646 1.8× 508 1.9× 232 1.0× 47 1.5k
Xiaoming Qiang China 20 757 1.1× 454 1.0× 414 1.2× 174 0.7× 359 1.5× 25 1.0k
Prabhash Nath Tripathi India 17 678 1.0× 474 1.1× 361 1.0× 378 1.4× 356 1.5× 31 1.3k
Óscar M. Bautista‐Aguilera Spain 12 455 0.7× 292 0.7× 303 0.9× 185 0.7× 127 0.5× 23 657
Zhongcheng Cao China 17 486 0.7× 320 0.7× 299 0.9× 133 0.5× 221 0.9× 27 719
Pavan Srivastava India 13 545 0.8× 376 0.9× 315 0.9× 319 1.2× 292 1.2× 15 1.1k
Ian R. Macdonald Canada 12 431 0.6× 277 0.6× 152 0.4× 177 0.7× 133 0.6× 29 694

Countries citing papers authored by Gerard Esteban

Since Specialization
Citations

This map shows the geographic impact of Gerard Esteban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard Esteban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard Esteban more than expected).

Fields of papers citing papers by Gerard Esteban

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard Esteban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard Esteban. The network helps show where Gerard Esteban may publish in the future.

Co-authorship network of co-authors of Gerard Esteban

This figure shows the co-authorship network connecting the top 25 collaborators of Gerard Esteban. A scholar is included among the top collaborators of Gerard Esteban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerard Esteban. Gerard Esteban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Esteban, Gerard, Ping Sun, Ann Van Eeckhaut, et al.. (2017). In-vitroandin-vivoevaluation of the modulatory effects of the multitarget compound ASS234 on the monoaminergic system. Journal of Pharmacy and Pharmacology. 69(3). 314–324. 10 indexed citations
2.
Pietro, Ornella Di, Gerard Esteban, Elisabet Viayna, et al.. (2016). Design, synthesis and biological evaluation of N-methyl-N-[(1,2,3-triazol-4-yl)alkyl]propargylamines as novel monoamine oxidase B inhibitors. Bioorganic & Medicinal Chemistry. 24(20). 4835–4854. 23 indexed citations
3.
Marco‐Contelles, José, Mercedes Unzeta, Irene Bolea, et al.. (2016). ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy. Frontiers in Neuroscience. 10. 294–294. 65 indexed citations
4.
Ismaïli, Lhassane, Bernard Refouvelet, Mohamed Benchekroun, et al.. (2016). Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease. Progress in Neurobiology. 151. 4–34. 151 indexed citations
5.
Unzeta, Mercedes, Gerard Esteban, Irene Bolea, et al.. (2016). Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease. Frontiers in Neuroscience. 10. 205–205. 125 indexed citations
6.
Wu, Mingyu, Gerard Esteban, Simone Brogi, et al.. (2015). Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation. European Journal of Medicinal Chemistry. 121. 864–879. 87 indexed citations
7.
Esteban, Gerard, Mercedes Giralt, Tony Valente, et al.. (2015). Catecholaminergic and cholinergic systems of mouse brain are modulated by LMN diet, rich in theobromine, polyphenols and polyunsaturated fatty acids. Food & Function. 6(4). 1251–1260. 19 indexed citations
8.
Sun, Ping, Gerard Esteban, Tsutomu Inokuchi, et al.. (2015). Protective effect of the multitarget compound DPH‐4 on human SSAO/VAP‐1‐expressing hCMEC/D3 cells under oxygen–glucose deprivation conditions: anin vitroexperimental model of cerebral ischaemia. British Journal of Pharmacology. 172(22). 5390–5402. 12 indexed citations
9.
Wang, Li, Gerard Esteban, Óscar M. Bautista‐Aguilera, et al.. (2014). Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 80. 543–561. 127 indexed citations
10.
Bautista‐Aguilera, Óscar M., Gerard Esteban, Mourad Chioua, et al.. (2014). Multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer’s disease: design, synthesis, biochemical evaluation, ADMET, molecular modeling, and QSAR analysis of novel donepezil-pyridyl hybrids. Drug Design Development and Therapy. 8. 1893–1893. 51 indexed citations
11.
12.
Esteban, Gerard, Abdelouahid Samadi, Andrea Mattevi, et al.. (2014). Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234, a multi-target compound designed for use in Alzheimer's disease. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1844(6). 1104–1110. 45 indexed citations
14.
Samadi, Abdelouahid, Mourad Chioua, Irene Bolea, et al.. (2011). Synthesis, biological assessment and molecular modeling of new multipotent MAO and cholinesterase inhibitors as potential drugs for the treatment of Alzheimer’s disease. European Journal of Medicinal Chemistry. 46(9). 4665–4668. 61 indexed citations
15.
Reid, Thomas, et al.. (1999). Cooling and Freezing Damage Platelet Membrane Integrity. Cryobiology. 38(3). 209–224. 30 indexed citations
16.
Reid, Thomas, et al.. (1999). Platelet membrane integrity during storage and activation. Transfusion. 39(6). 616–624. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026